A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae

By K. Nash, B. Brown-Elliott, Richard J. Wallace. Antimicrobial Agents and Chemotherapy, 2009

598 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases, Small Animals

View Paper: https://www.semanticscholar.org/paper/434e7a91cf5657890f9342051f9c4b5dd215d2d2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. T. Marras
2. Richard J. Wallace

In Infectious Diseases

1. T. Marras
2. Richard J. Wallace

In Small Animals

1. T. Marras
2. Richard J. Wallace

Citations in the corpus

• Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline (2020, background): “bolletii have an erythromycin resistance methylase (erm) gene, named erm(41), that results in inducible resistance to macrolides [93].”